INNOVATE Corp.
corporate_fare Company Profile
INNOVATE Corp. (NYSE:VATE) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 29 items for VATE at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- INNOVATE Corp. Seeks Shareholder Approval to Expand Equity Award Plan Amid Going Concern Warning
- INNOVATE Corp. Seeks 5.7% Potential Dilution via Equity Plan Expansion Amidst Going Concern
- INNOVATE Subsidiary DBM Global to Pay $2.7M Cash Dividend to Parent Company
- INNOVATE's Equity Investment MediBeacon Receives EU CE Mark for Kidney Function Monitor
- INNOVATE Corp. Discloses Going Concern Doubt, Worsening Net Loss, and Mandatory Asset Sales Amidst Debt Maturities
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.25B
Net Income
-$60.6M
Diluted EPS
-$4.84
Op. Cash Flow
$146.6M
Free Cash Flow
$146.1M
Gross Profit
$199.7M
Operating Income
$28.7M
Cash & Equivalents
$112.1M
Total Debt
$581.4M
Debt / Equity
-2.42×
Net Margin
-4.9%
Shares Outstanding
13.66M sh
Source: 10-K · filed 2026-03-26 · accession 0001006837-26-000014
show_chartPrice Chart
Loading chart...
feed VATE - Filings & News (Page 2)
VATE
Apr 28, 2026, 4:32 PM EDT
Price at Filing:
$12.33
Real-time Price:
$3.55
Change:
-$8.78 (-71%)
Market Cap:
$49.184M
VATE
Apr 28, 2026, 4:32 PM EDT
Price at Filing:
$12.33
Real-time Price:
$3.55
Change:
-$8.78 (-71%)
Market Cap:
$49.184M
VATE
Apr 06, 2026, 8:39 AM EDT
Price at Filing:
$6.51
Real-time Price:
$3.55
Change:
-$2.96 (-45%)
Market Cap:
$49.184M
VATE
Mar 31, 2026, 9:00 AM EDT
Price at Filing:
$5.62
Real-time Price:
$3.55
Change:
-$2.07 (-37%)
Market Cap:
$49.184M
VATE
Mar 26, 2026, 4:27 PM EDT
Price at Filing:
$4.05
Real-time Price:
$3.55
Change:
-$0.500 (-12%)
Market Cap:
$49.184M
VATE
Mar 26, 2026, 4:17 PM EDT
Price at Filing:
$4.05
Real-time Price:
$3.55
Change:
-$0.500 (-12%)
Market Cap:
$49.184M
VATE
Mar 26, 2026, 4:17 PM EDT
Price at Filing:
$4.03
Real-time Price:
$3.55
Change:
-$0.480 (-12%)
Market Cap:
$49.184M
VATE
Feb 10, 2026, 4:08 PM EST
INNOVATE's MediBeacon Subsidiary Receives Top Medical Journal Recognition for Kidney Function System
Price at Filing:
$5.42
Real-time Price:
$3.55
Change:
-$1.87 (-35%)
Market Cap:
$49.184M
VATE
Feb 02, 2026, 8:32 AM EST
Price at Filing:
$5.63
Real-time Price:
$3.55
Change:
-$2.08 (-37%)
Market Cap:
$49.184M